Molecular identification of mutations conferring resistance to rifampin, isoniazid and pyrazinamide among Mycobacterium tuberculosis isolates from Iran
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Chemotherapy"
DOI: 10.1080/1120009x.2020.1716479
Abstract: Here, we aimed to determine the susceptibility of 70 Mycobacterium tuberculosis isolates obtained from different regions of the country to 8 anti-tuberculosis (anti-TB) drugs and possible underlying mechanisms causing resistance to rifampin, isoniazid, and pyrazinamide.… read more here.
Keywords: mycobacterium tuberculosis; tuberculosis isolates; resistance; tuberculosis ... See more keywords
Adverse events of anti-IL-5 drugs in patients with eosinophilic asthma: a meta-analysis of randomized controlled trials and real-world evidence-based assessments
Sign Up to like & getrecommendations! Published in 2024 at "BMC Pulmonary Medicine"
DOI: 10.1186/s12890-024-02885-2
Abstract: Background We aimed to clarify comprehensively the safety profiles of anti-IL-5 drugs and pinpoint potential safety concerns that may arise in their post-marketing phase. Methods Two researchers conducted comprehensive searches of PubMed, EMBASE, Web of… read more here.
Keywords: adverse events; product; events anti; anti drugs ... See more keywords
Resistance To First-Line Antituberculosis Drugs And Prevalence Of pncA Mutations In Clinical Isolates Of Mycobacterium tuberculosis From Zunyi, Guizhou Province Of China
Sign Up to like & getrecommendations! Published in 2019 at "Infection and Drug Resistance"
DOI: 10.2147/idr.s222943
Abstract: Background China is one of the high-burden countries for multidrug-resistant tuberculosis (MDR-TB), and pyrazinamide is one of the anti-TB drugs used for the shorter MDR-TB treatment regimen. The aim of this study was to determine… read more here.
Keywords: anti drugs; pnca mutations; clinical isolates; first line ... See more keywords
Understanding the Reciprocal Interplay Between Antibiotics and Host Immune System: How Can We Improve the Anti-Mycobacterial Activity of Current Drugs to Better Control Tuberculosis?
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2021.703060
Abstract: Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb) infection, remains a global health threat despite recent advances and insights into host-pathogen interactions and the identification of diverse pathways that may be novel therapeutic targets for TB… read more here.
Keywords: host immune; immune system; tuberculosis; anti drugs ... See more keywords